[Cardiorenal syndrome and its pathophysiological implications].

Area of Science:

• Cardiology
• Nephrology
• Pathophysiology

Context:

• Cardiorenal syndrome is a complex condition where heart and kidney dysfunction exacerbate each other.
• Increasing longevity contributes to a rise in cardiorenal syndrome incidence.
• This syndrome leads to significantly higher morbidity and mortality rates.

Purpose:

• To review recent advancements in understanding cardiorenal syndrome.
• To propose a novel classification system (Types I-V) for better comprehension and systematization.
• To highlight the role of biomarkers in early diagnosis and risk stratification.

Summary:

• Cardiorenal syndrome (CRS) involves combined cardiac and renal dysfunction.
• A proposed classification includes Type I (acute cardiac worsening -> AKI), Type II (chronic cardiac dysfunction -> CKD), Type III (acute renal worsening -> cardiac dysfunction), Type IV (CKD -> cardiac dysfunction), and Type V (systemic disease affecting both organs).
• Biomarkers offer potential for early diagnosis and management.

Impact:

• The proposed classification aids in identifying underlying abnormalities.
• It facilitates the establishment of effective therapeutic strategies for cardiorenal syndrome.
• Early diagnosis and stratification using biomarkers can improve patient outcomes.